CoRegen
CoRegen is a startup headquartered in Houston, United States, founded in 2022. It has raised at least $134.3m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the growth stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
CoRegen has raised at least $134.3m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
CoRegen sits inside the Houston R&D ecosystem in the Global R&D Labs Directory.
Other startups in Houston
- Ally Energy
- AMPeers
- Arriba Foods
- AstroMind
- Atana Elements
- ATAP Market Technologies
- Autoimmunity Biologic Solutions
- Axiom Space
- Bectas Therapeutics
- Biostate AI
- Branch Therapeutics
Related
- Innovation profile of Houston
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does CoRegen do?
CoRegen is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has CoRegen raised?
At least $134.3m, according to its Form D filings with the US Securities and Exchange Commission.
Where is CoRegen based?
CoRegen is headquartered in Houston, United States.
When was CoRegen founded?
CoRegen was founded in 2022.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.